Clinical trial
A Phase II Trial of High-Dose Vitamin D Induction in Optic Neuritis (VitaDON 2)
NCT03302585 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Trial of High-Dose Vitamin D Induction in Optic Neuritis (VitaDON 2)
- Lead sponsor
- University of Calgary
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- November 23, 2017
- Completion date
- May 9, 2024
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.